Stock Market News — November 06, 2026 — Friday Evening — Last 12 Hours (Pacific Time)

Executive Summary

Wall Street staged a partial Friday recovery after Thursday's brutal AI-driven selloff, but the Nasdaq still logged its fourth consecutive weekly decline — its worst week since mid-October. The dominant narrative remains a post-midterm reckoning for AI and chip stocks, as Democratic congressional wins raised fears of tighter AI regulation and data-center spending scrutiny. Meanwhile, OpenAI closed $11 billion in fresh funding at a $1.25 trillion valuation, signaling that private AI capital markets remain very much open for business.

Sentiment Breakdown

Net Sentiment: Bearish — Despite Friday's bounce, the week's AI regulatory fears, European market declines, record options volume, and multiple stock plunges outweigh isolated bright spots in private AI funding and select earnings beats.

Top Market-Moving Headlines

🔴 Macro/Markets | Nasdaq rebounds but posts fourth straight weekly decline
Market Impact: Tech clawed back some losses Friday but couldn't escape a brutal week triggered by AI regulation fears post-midterms. The index's four-week losing streak signals sustained institutional pressure on growth names.

🟢 Private Markets/AI | OpenAI secures $11 billion funding at $1.25 trillion valuation
Market Impact: OpenAI closed the first tranche of a new round at a staggering $1.25 trillion valuation, underscoring that private AI capital appetite remains insatiable even as public AI stocks reel.

🔴 AI/Cloud | Microsoft winds down Oracle deal to rent AI cloud capacity
Market Impact: Microsoft is reassessing its AI computing rental arrangements, directly hitting Oracle shares by 4%. This signals hyperscalers may be pulling back on third-party AI cloud spending in favor of owned infrastructure.

🔴 Autos | Tesla to pull the plug on Cybertruck after years of poor sales
Market Impact: Tesla will wind down Cybertruck production at its Texas Gigafactory around mid-2027, ending a product plagued by 11 recalls, cracked windows, and long delays — a significant brand and revenue setback.

🟢 AI/Infrastructure | Goldman raises global data center capacity forecast to 273 GW by 2030
Market Impact: Goldman Sachs lifted its 2030 data center capacity forecast from 217 GW to 273 GW, a bullish long-term signal for power, cooling, and infrastructure plays even amid near-term regulatory noise.

🟢 AI Funding | Nvidia-backed Groq seeks $8 billion valuation in new funding round
Market Impact: Groq is pursuing fresh capital at an $8 billion valuation, reflecting continued investor conviction in AI inference infrastructure despite the public market selloff in chip stocks.

🔴 Politics/AI | Democrats planning flood of AI bills when they take control of Congress
Market Impact: Incoming Democratic majorities are preparing sweeping AI legislation, the catalyst behind this week's tech rout. Regulatory uncertainty is now a concrete near-term risk for AI and semiconductor names.

🟢 Real Estate/AI | Google acquires Wyoming data center site from Crusoe
Market Impact: Alphabet is buying — not renting — AI data center capacity, reflecting a broader hyperscaler shift toward owning infrastructure outright. Bullish for Google's long-term AI positioning.

🔴 Semiconductors | Onsemi and Czech ministry cancel $2 billion chip facility expansion
Market Impact: ON Semiconductor scrapped a multi-year $2 billion Czech expansion, a significant retreat that raises questions about chip capex confidence amid shifting demand signals.

🟢 Pharma/Telehealth | Hims & Hers stock climbs on direct partnership with Eli Lilly for obesity drugs
Market Impact: Shares rose 6.3% after Hims & Hers struck a direct deal with Eli Lilly for obesity medications, bypassing traditional pharmacy channels and potentially reshaping the GLP-1 distribution landscape.

🟢 Semiconductors | SiTime shares surge 16% as Seaport upgrades to Buy
Market Impact: SiTime rallied 16% on a fresh Buy rating from Seaport Global and was also named Rosenblatt's top semiconductor pick, making it a rare bright spot in a battered chip sector.

🔴 Healthcare | Globus Medical stock plunges 12.5% to fresh 52-week low
Market Impact: Shares hit a new 52-week low after disappointing results, adding to the week's broad-based pain in medical device names.

🟢 Semiconductors/AI | AMD surges nearly 9.9% clawing back post-selloff losses
Market Impact: Advanced Micro Devices led the chip recovery Friday, bouncing sharply after Thursday's AI-driven rout — though the move is seen as a relief rally rather than a trend reversal.

🟢 Cloud/Software | Cloudflare beats on every line; shares up ~11%
Market Impact: Cloudflare's clean Q3 beat across all metrics drove an ~11% gain, one of the strongest earnings reactions of the week and a positive signal for enterprise security/networking demand.

🔴 Biotech | Inovio Pharmaceuticals plunges nearly 19.7%
Market Impact: Shares collapsed to $1.165 after a negative clinical or regulatory development, highlighting continued binary risk in small-cap biotech.

🟡 Space/Defense | SpaceX government contracts to fall below 10% of revenue — Musk
Market Impact: Elon Musk disclosed that US government payments will drop to under 10% of SpaceX revenue this quarter, a notable shift in the company's revenue mix toward commercial sources.

🟡 Corporate Governance | Google executive Donald Harrison resigns from SpaceX board
Market Impact: The departure of a senior Google executive from SpaceX's board raises questions about the Alphabet-SpaceX relationship, though the immediate financial impact is unclear.

🟢 M&A | AkzoNobel and Axalta secure conditional EU antitrust approval for $25 billion merger
Market Impact: The EU green-lighting this major paint industry combination signals regulators remain open to large industrial mergers, with conditions attached.

🔴 Consumer | Under Armour flags broad-based weakness, steeper-than-expected Q3 sales decline
Market Impact: Under Armour warned of deeper revenue weakness across its portfolio, adding to concerns about discretionary consumer spending heading into the holiday season.

🟡 IPO | Apollo-backed vVardis targets up to $229 million US IPO at up to $24/share
Market Impact: The Swiss dental tech startup's IPO attempt tests appetite for healthcare listings in a volatile market environment — outcome will be a read on IPO window conditions.

Tickers in Focus

Market Implications

The post-midterm AI regulatory overhang is the defining risk factor heading into next week. With Democrats set to control Congress and promising a wave of AI legislation, the market is repricing the regulatory premium on AI infrastructure stocks — a shift that won't resolve quickly. Investors should watch for any early signals on the legislative agenda's scope, particularly whether it targets data center permitting, chip exports, or model deployment. The VIX dropping 14.25% on Friday suggests some fear has been wrung out, but four consecutive weekly Nasdaq declines argue against calling a bottom yet.

The Microsoft-Oracle AI cloud rental unwind is a microcosm of a larger structural shift: hyperscalers are moving to own rather than rent AI capacity, as Google's Wyoming data center acquisition also illustrates. This is a headwind for cloud infrastructure resellers and a tailwind for companies that own land, power, and physical assets. Goldman's upgraded 273 GW data center forecast by 2030 keeps the long-term capex story intact, but near-term spending rationalization could create winners and losers across the supply chain.

Next week's US inflation data is the macro wildcard. With the S&P 500 at 7,407.94 and markets already on edge from the tech rout, a hotter-than-expected CPI print could compound selling pressure by pushing back Fed rate-cut expectations. Fed speakers and Treasury auctions on Monday's calendar will set the tone. The STOXX 600 overtaking the S&P 500 in year-to-date gains is a notable rotation signal — European equities may be attracting capital fleeing US tech concentration risk.

Key Takeaways

• 🔴 Nasdaq — Fourth straight weekly decline confirms the AI regulatory selloff is a trend, not a one-day event
• 🟢 OpenAI — $11B raised at $1.25T valuation; private AI markets are decoupled from public market fear
• 🔴 ORCL — Microsoft ending AI cloud rental deal is a direct revenue threat; -4% Friday is likely not the end
• 🔴 TSLA/Cybertruck — Production wind-down by mid-2027 closes the chapter on Tesla's most troubled product (11 recalls)
• 🟢 SITM — SiTime's 16% surge on dual analyst upgrades makes it the semiconductor sector's standout survivor this week
• 🟢 HIMS — Eli Lilly direct partnership is a structural positive; bypassing traditional pharmacy could be a game-changer
• 🔴 AXON — Down 18.24% to a 52-week low; earnings disappointment hits hard in a risk-off environment
• 🟢 NET — Cloudflare's clean beat and ~11% gain shows enterprise software demand remains healthy
• 🔴 ON — Cancelling a $2B chip expansion signals wavering confidence in long-cycle semiconductor capex
• 🟢 Goldman/Data Centers — 273 GW forecast by 2030 (up from 217 GW) keeps the infrastructure buildout thesis alive long-term
• 🟢 GOOGL — Buying Wyoming data center outright signals hyperscalers want to own AI infrastructure, not lease it
• 🔴 Democrats/AI Bills — Incoming legislative flood is the root cause of this week's tech rout; watch for bill specifics
• 🟢 Groq — Seeking $8B valuation in new round; Nvidia-backed AI inference play attracting capital despite public market chaos
• 🔴 European Markets — DAX -2.02%, FTSE -1.20%, CAC -0.81%; AI contagion went global and STOXX 600 now leads S&P YTD
• 🟡 SpaceX — Government revenue falling below 10% of total; commercial pivot accelerating, board changes add intrigue
• 🟢 UI (Ubiquiti) — +16.9% on landmark earnings; networking hardware demand holding up well
• 🔴 MNST — Monster Beverage -3.7% on Q3 miss; consumer staples showing cracks
• 🟡 Inflation Data — Next week's CPI is the macro swing factor; a hot print could extend the tech selloff
• 🟢 CGON — CG Oncology +19.7% on Q3 results; biotech bright spot amid broader healthcare weakness
• 🟡 vVardis IPO — Apollo-backed dental tech targeting $229M at up to $24/share; a live test of IPO market conditions

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

👉 This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/